Abdel-Aal Abu-Baker M., El-Naggar D., Zaman M., Batzloff M., Toth I. Design fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based Toll-like receptor ligand // J. Med. Chem. - 2012. - V. 55. - № 15. - Р. 6968-74.
Abdel-Hag N.M., Asmar B.I. Human herpesvirus 6 (HHV-6) infection // Indian Journal
of Pediatrics. - 2004. - V. 71. - № 1. - P. 89-96. Actinic Keratosis. Net: American Academy of Dermatology Web site. Available at: www.
skincarephysicians.com
Agace WW., Hedges S.R., Ceska M., Svanborg C. Interleukin-8 and the neutrophil response to mucosal gram-negative infection // J. Clin. Invest. - 1993. - V. 92 (2). - P. 780-5.
Agut H., Bonnafous P., Gautheret-Dejean A. Laboratory and clinical aspects of human herpesvirus 6 infections // Clinical Microbiology Reviews. - 2015. - V. 28 - № 2. -
Р. 313-35.
Akdis M., Verhagen J., Taylor A. et al. Immune responses in healthy and allergic individuals
are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2
cells // J. Exp. Med. - 2004. - V. 199. - P. 1567-75. Akhtar J., Shukla D. Viral entry mechanisms: cellular and viral mediators of herpes simplex virus
entry // FEBS Journal. - 2009. - V. 276. - № 24. - Р. 7228-36. Alejandria M.M., Lansang M.A., Dans L.F., Mantaring J.B.V. [Review] Intravenous
immunoglobulin for treating sepsis and septic shock // The Cochrane Database
of Systematic Reviews. - 2006. - Issue 4. Allen B. A multicentre double-blind placebo controlled crossover to assess the efficacy and safety
of cyclosporin A in adult patients with severe refractory atopic dermatitis // Royal Society
of Medicine Services Ltd; Athens, Greece : London. - 1991. Amery W.K. The mechanism of action of levamisole: immune restoration through enhanced